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The dinuclear ruthenium complexes Ru2(CO)4(OOCC5H4FeC5H5)2L2 (L = NC5H5: 1, L = PPh3: 2) have been synthesized from
Ru3(CO)12, ferrocene carboxylic acid and pyridine or triphenylphosphine, respectively. The single-crystal X-ray structure analysis reveals
for 1 and 2 a Ru2(CO)4 sawhorse backbone with the two ferrocenyl substituents of the two carboxylato bridges being endo/exo with
respect to each other in the solid state. With the new pyridine derivative NC5H4OOCC5H4FeC5H5 (4-ferrocenoyl pyridine) (3) as axial
ligand, the complex Ru2(CO)4(OOCC5H4FeC5H5)2(NC5H4OOCC5H4FeC5H5)2 (4) was obtained, the single crystal X-ray structure anal-
ysis showing an exo/exo orientation of the two carboxylato bridges in the solid state. The endo/endo orientation is found in the solid-state
structure of Ru2(CO)4(HNOCC5H4FeC5H5)2(PPh3)2 (5), the two OCNH bridges being transoı¨d with respect to each other; this complex
is accessible from Ru3(CO)12, ferrocenamide and triphenylphosphine.
Keywords: Carbonyl ligands; Carboxylato bridges; Carbamido bridges; Ferrocenyl substituents; Dinuclear complexes; Ruthenium1. Introduction
Sawhorse-type ruthenium complexes are well-known
since 1969, when Lewis and co-workers [1] reported the for-
mation of [Ru2(CO)4(OOCR)2]n polymers by reﬂuxing
Ru3(CO)12 in the corresponding carboxylic acid and the
depolymerization of these materials in coordinating sol-
vents to give dinuclear complexes of the type Ru2(CO)4-
(OOCR)2L2, L being acetonitrile, pyridine or another
two-electron donor. These dinuclear complexes have been
shown later, by a single-crystal X-ray structure analysis
of Ru2ðCOÞ4ðOOCBunÞ2ðPBut3Þ2 to have a Ru2(CO)4 back-
bone in a sawhorse-type arrangement with two l2-g
2-carb-* Corresponding author. Tel.: +41 032 7182499; fax: +41 032 7182511.
E-mail address: georg.suess-ﬁnk@unine.ch (G. Su¨ss-Fink).oxylato bridges and two axial (phosphine) ligands [2]. In
the meantime, a considerable number of such sawhorse-
type diruthenium complexes with carboxylato [3], carboxa-
mido [4], phosphinato [5], sulfonato [6], pyrazolato [7] or
oximato [8] bridges have been synthesized and used in
catalysis [8,9] or for the assembly of mesomorphic materi-
als [10] (see Scheme 1).
Herein, we report the synthesis and molecular structure
of new Ru2(CO)4 sawhorse-type complexes containing ferr-
ocenyl substituents in the carboxylato or carboxamido
bridges and in one case also in the axial ligand: Ru2-
(CO)4(OOCC5H4FeC5H5)2L2 (L = NC5H5: 1, L = PPh3:
2, L = NC5H4OOCC5H4FeC5H5: 4) and Ru2(CO)4(H-
NOCC5H4FeC5H5)2(PPh3)2 (5), obtained from Ru3(CO)12,
ferrocene carboxylic acid and pyridine, triphenylphosphine
or 4-ferrocenoyl pyridine (3) and from Ru3(CO)12, ferroce-
namide and triphenylphosphine, respectively.
Scheme 1.
22. Results and discussion
Dodecacarbonyltriruthenium reacts with ferrocene car-
boxylic acid in reﬂuxing tetrahydrofuran to give, in the
presence of pyridine or triphenylphosphine, the dinuclear
complexes Ru2(CO)4(OOCC5H4FeC5H5)2L2 (L = NC5H5:
1, L = PPh3: 2) in good yields. Compounds 1 and 2 are
air-stable brown-yellowish crystalline materials, which
have been unambiguously characterized by their IR,
NMR and MS data (see Scheme 2).
2Ru3(CO)12 + 6C5H5FeC5H4COOH+6L
!3Ru2(CO)4(OOCC5H4FeC5H5)2L2 + 12CO+3H2 ð1Þ
The single-crystal X-ray structure analyses of 1 and 2
reveal in both cases the typical Ru2(CO)4 sawhorse back-
bone with two ferrocenyl carboxylato bridges, the Ru–Ru
distances (1: 2.6854(5) A˚, 2: 2.7330(5) A˚) being in the range
of a ruthenium–ruthenium single bond, as it was also
observed in analogous complexes [2,3b,3d,11]. The OCO
bond angles of the two carboxylato bridges (1: 125.7(4)
and 124.6(4), 2: 125.5(3)) diﬀer only slightly from those
observed in other Ru2(CO)4(OOCR)2L2 complexes [2,3b,Scheme 2.
Scheme3d,11]. In the solid state, the two ferrocenyl substituents
at the two carboxylato bridges in 1 and 2 adopt an endo/
exo orientation.
In order to introduce ferrocenyl substituents not only in
the carboxylato bridges, but also in the axial ligand posi-
tions of these sawhorse-type complexes, we synthesized
4-ferrocenoyl pyridine (3), a new ligand accessible from fer-
rocene carboxylic acid and 4-hydroxypyridine in the
presence of N,N 0-dicyclohexylcarbodiimide, 4-pyrrolidino-
pyridine and dimethylaminopyridine as condensation auxil-
iaries [12]. Compound 3 is an orange air-stable crystalline
substance, the single-crystal X-ray analysis of which shows
the expected molecular structure (see Scheme 3).
The reaction of Ru3(CO)12 with ferrocene carboxylic acid
in reﬂuxing THF gives, in the presence of ligand 3, according
to Eq. (1), the dinuclear complex Ru2(CO)4(OOCC5H4-
FeC5H5)2(NC5H4OOCC5H4FeC5H5)2 (4), isolated in the
same manner as 1 and 2. The solid state molecular structure
of 4 shows the sameRu2(CO)4 sawhorse backbone as 1 and 2
(Ru–Ru: 2.6850(7) A˚) (see Scheme 4).
However, while the two ferrocenyl substituents in the
two axial pyridine ligands are transoı¨d with respect to each
other, the orientation of the two ferrocenyl substituents in
the two carboxylato bridges is exo/exo, both being oriented
outwards, in contrast to the exo/endo orientation found in
1 and 2.
Moreover, in the solid state, two molecules of chloro-
form per molecule of 4 are found in the crystal, one of them
being encapsulated between the two ferrocenyl substituents
of the bridging ligands, see Fig. 4. The distance between the
centroid of the cyclopentadienyl and the hydrogen atom of
the chloroform molecule is only 2.47 A˚.
The missing endo/endo orientation of the two ferrocenyl
substituents in the two bridging ligands was ﬁnally found in3.
Scheme 4.
Scheme 5.
3the solid state structure of the carboxamido derivative
Ru2(CO)4(HNOCC5H4FeC5H5)2(PPh3)2 (5), accessible
from Ru3(CO)12, ferrocenamide and triphenylphosphine
(see Scheme 5). However, 5 is not very stable: although it
can be isolated in the solid state, it is very hygroscopic
and decomposes quickly in solution, even under inert
atmosphere.
In conclusion, we have synthesized and structurally
characterized four new Ru2(CO)4 sawhorse-type complexes
containing l2-g
2-ferrocene carboxylato or carbamido
ligands as well as a new ferrocenyl pyridine derivative.
All possible conformations (endo/endo, exo/exo and endo/
exo) of the two ferrocenyl substituents in the bridging
ligands have been observed in the solid state.
3. Experimental
3.1. General
All manipulations were carried out by routine under
nitrogen atmosphere. De-ionized water and organic sol-
vents were degassed and saturated with nitrogen prior to
use. All reagents were purchased either from Aldrich or
Fluka and used as received. NMR spectra were recorded
on a Bruker 400 MHz spectrometer. IR spectra were
recorded on a Perkin–Elmer 1720X FT-IR spectrometer
(4000–400 cm1). Microanalyses were performed by the
Laboratory of Pharmaceutical Chemistry, University of
Geneva (Switzerland). Electro-spray mass spectra were
obtained in positive-ion mode with an LCQ Finnigan mass
spectrometer. Dodecacarbonyltriruthenium [13] and fer-
rocenamide [14] was prepared according to published
methods.
3.2. General method for the preparation of complexes 1, 2
and 4
A solution of Ru3(CO)12 (100 mg, 0.16 mmol) and ferro-
cene carboxylic acid (108 mg, 0.47 mmol) in dry tetrahy-
drofuran (25 ml) was heated at 120 C in a pressure
Schlenk tube for 12 h. Then the solvent was evaporated
to give an orange-brown residue which was dissolved in tet-
rahydrofuran and the appropriate ligand L (0.47 mmol)
was added. The solution was stirred at room temperaturefor 2 h, the solution was evaporated and the product iso-
lated from the residue by crystallization from a tetrahydro-
furan/hexane mixture. In order to improve the purity, the
raw product was subjected to a thin-layer chromatography
on silica gel using dichloromethane as eluent and obtained
as yellow-brown powder.
Ru2(CO)4(OOCC5H4FeC5H5)2(NC5H5)2 (1): Yield: 84%
(122 mg, 0.13 mmol). 1H NMR (400 MHz, CDCl3):
d = 8.92 (m, 4H), 7.94 (m, 2H), 7.54 (m, 4H), 4.60 (t,
4H), 4.20 (t, 4H), 4.08 (s, 10H); 13C{1H} NMR
(100 MHz, CDCl3): d = 197.32 (2C), 184.0 (4C), 152.40
(4C), 137.75 (2C), 125.10 (4C), 75.84 (2C), 70.62 (4C),
70.55 (4C), 69.96 (10C); IR (CaF2, THF): m(CO) 2021 vs,
1969 m, 1938 vs, m(OCO) 1559 s cm
1; ESI–MS: 904
[M  CO + H+], 825 [M  CO  NC5H5 + H+], 773
[M  2{NC5H5}]; Anal. Calc. for C36H28Fe2N2O8Ru2
(930.45), C, 46.47; H, 3.03; N, 3.01. Found: C, 46.87; H,
3.27; N, 2.91%.
Ru2(CO)4(OOCC5H4FeC5H5)2(PPh3)2 (2): Yield: 64%
(133 mg, 0.10 mmol). 1H NMR (400 MHz, CDCl3):
d = 7.76–7.72 ppm (m, 12H), 7.50–7.48 (m, 18H), 4.14 (t,
4H), 4.08 (t, 4H), 3.94 (s, 10H); 13C{1H} NMR
(100 MHz, CDCl3): d = 206.08 ppm (2C), 186.2 (4C),
134.25 (18C), 128.83 (18C), 75.88 (2C), 70.74 (4C), 70.60
(4C), 69.90 (10C); 31P{1H} NMR (162 MHz, CDCl3):
d = 14.70 ppm; IR (CaF2, THF): m(CO) 2022 vs, 1977 m,
1951 vs, m(OCO) 1552 s cm
1; ESI–MS: 1333 [M + 2H2O],
1315 [M + H2O]; Anal. Calc. for C62H48Fe2O8-
P2Ru2(1296.84), C, 57.42; H, 3.99. Found: C, 57.23; H,
3.99%.
Ru2(CO)4(OOCC5H4FeC5H5)2(NC5H4OOCC5H4FeC5-
H5)2 (4): Yield: 81% (177 mg, 0.13 mmol).
1H NMR
(400 MHz, CDCl3): d = 8.95 ppm (d, 4H), 7.48 (d, 4H),
5.05 (t, 4H), 4.63 (m, 8H), 4.38 (s, 10H), 4.22 (m, 4H), 4.12
(s, 10H); 13C{1H} NMR (100 MHz, CDCl3):
d = 205.00 ppm (2C), 184.11 (4C), 169.50 (2C), 159.16
(2C), 153.89 (4C), 118.15 (4C), 87.8 (2C), 75.5 (2C), 73.12
(4C), 71.24 (4C), 70.60 (18C), 70.01 (10C); IR (CaF2,
THF): m(CO) 2021 vs, 1969 m, 1939 vs, m(OCO) 1560 s cm
1;
ESI–MS: 1389 [M + 2H+]; 1360 [M  CO + H+]; 1159
[M  (C5H5FeC5H4–CO2)]; 1104 [M  (C5H5FeC5H4–
CO2)–CO]; 1080 [M  (C5H5FeC5H4–CO2–C5H4N)]; 971
[M  (C5H5FeC5H4–CO2–C5H4N)–4CO]; 773 [M  2-
(C5H5FeC5H4–CO2–C5H4N)]; Anal. Calc. for C58H44Fe4-
N2O12Ru2 (1386.5), C, 50.24; H, 3.20. Found: C, 49.60; H,
3.04% ðC58H44Fe4N2O12Ru2  18C4H8OÞ.
3.3. Preparation of 4-ferrocenoyl pyridine,
NC5H4OOCC5H4FeC5H5 (3)
In a pressure Schlenk tube was introduced ferrocene car-
boxylic acid (500 mg, 2.17 mmol), N,N 0-dicyclohexylcarbo-
diimide (688 mg, 3.34 mmol), dimethylaminopyridine
(204 mg, 1.67 mmol), 4-pyrrolidinopyridine (124 mg,
0.83 mmol) and hydroxypyridine (159 mg, 1.67 mmol) in
anhydrous dichloromethane (30 ml). The solution was stir-
red under nitrogen at room temperature for 36 h without
Table 1
Crystallographic and selected experimental data of compounds 1, 2, 3, 4, and 5
1 Æ THF 2 3 4 Æ 2 CHCl3 5
Chemical formula C40H36Fe2N2O9Ru2 C62H48Fe2O8P2Ru2 C16H13FeNO2 C60H46Cl6Fe4N2O12Ru2 C62H50Fe2N2O6P2Ru2
Formula weight 1002.55 1296.78 307.12 1625.23 1294.82
Crystal system monoclinic monoclinic triclinic triclinic trigonal
Space group P21 P21/m P1 P1 R3c
Crystal colour and shape orange block orange block orange plate orange block orange block
Crystal size 0.32 · 0.26 · 0.18 0.40 · 0.30 · 0.30 0.25 · 0.25 · 0.12 0.32 · 0.22 · 0.10 0.38 · 0.34 · 0.15
a (A˚) 10.2754(8) 11.8573(8) 5.8020(10) 13.8596(12) 26.434(4)
b (A˚) 17.0987(13) 17.8627(9) 10.242(2) 14.2649(12) 26.434(4)
c (A˚) 11.1261(8) 12.6909(8) 11.288(2) 17.5106(15) 40.754(8)
a () 90 90 93.14(3) 113.829(10) 90
b () 106.540(9) 102.862(8) 103.98(3) 91.681(10) 90
c () 90 90 97.93(3) 102.787(10) 120
V (A˚3) 1873.9(2) 2620.5(3) 642.0(2) 3060.8(5) 24662(7)
Z 2 2 2 2 18
T (K) 173(2) 173(2) 173(2) 173(2) 173(2)
Dcalc (g cm
3) 1.777 1.643 1.589 1.763 1.569
l (mm1) 1.609 1.227 1.173 1.729 1.172
Scan range () 3.82 < 2h < 51.84 4.0 < 2h < 51.88 4.04 < 2h < 52.24 4.04 < 2h < 52.0 4.3 < 2h < 51.96
Unique reﬂections 7241 5257 2353 11170 5031
Reﬂections used [I > 2r(I)] 6268 3588 1806 6475 3805
Rint 0.0483 0.0583 0.0438 0.0394 0.0363
Final R indices [I > 2r(I)] 0.0298, wR2 0.0626 0.0268, wR2 0.0520 0.0329, wR2 0.0722 0.0515, wR2 0.1253 0.0307, wR2 0.0736
R indices (all data) 0.0377, wR2 0.0641 0.0517, wR2 0.0549 0.0496, wR2 0.0781 0.0922, wR2 0.1382 0.0468, wR2 0.0812
Goodness-of-ﬁt 0.948 0.839 0.937 0.889 0.918
Maximum, Minimum Dq/e (A˚3) 0.662, 0.957 0.522, 1.086 0.416, 0.816 1.772, 1.497 0.727, 0.709
4light. Then the red solution was slowly ﬁltered on Celite to
eliminate the dicyclohexylurea. The product was obtained
as an orange powder by column chromatography on silica
gel using hexane/acetone (10:1) as eluent (265 mg,
0.86 mmol). Yield: 52%. 1H NMR (400 MHz, CD3OD):
d = 8.61 (dd, 2H), 7.40 (dd, 2H), 4.99 (t, 2H), 4.65 (t,
2H), 4.36 (s, 5H); IR (CaF2, THF): 1742 cm
1; ESI–MS:
308 [M + H+]; Anal. Calc. for C16H13FeNO2(307.12) C,
62.57; H, 4.27; N, 4.56. Found: C, 62.52; H, 4.56; N, 4.36%.Fig. 1. Molecular structure of Ru2(CO)4(OOCC5H4FeC5H5)2L2 (L = NC5H5
omitted for clarity. Selected bond distances (A˚), angles and torsion angles (
2.107(3), Ru1–O7 2.143(3), Ru2–O2 2.136(3), Ru2–O8 2.125(3), O1–C1–O2
2.7330(5), Ru1–P1 2.4462(7), Ru1–O1 2.125(2), Ru1–O2 2.124(2), O1–C1–O13.4. Preparation of
Ru2(CO)4(HNOCC5H4FeC5H5)2(PPh3)2 (5)
A solution of Ru3(CO)12 (200 mg, 0.31 mmol) and fer-
rocenamide (215 mg, 0.94 mmol) in dry tetrahydrofuran
(25 ml) was heated at 120 C in a pressure Schlenk tube
for 12 h. Then the solvent was evaporated to give a brown
residue which was dissolved in tetrahydrofuran and the tri-
phenylphosphine (250 mg, 0.94 mmol) was added. The: 1, L = PPh3: 2), the hydrogen atoms, and in 1 the THF molecule, are
): (1) Ru1–Ru2 2.6854(5), Ru1–N1 2.221(3), Ru2–N2 2.228(4), Ru1–O1
124.6(4), O7–C21–O8 125.7(4), N1–Ru1–Ru2–N2 12.1(5); (2) Ru1–Ru1i
i 125.5(3), O2–C8-O2i 126.4(4), (i = x, 1.5  y, z).
Fig. 2. Molecular structure of NC5H4OOCC5H4FeC5H5 (3), hydrogen
atoms are omitted for clarity. Selected bond distances (A˚), angles and
torsion angles (): C11–O1 1.196(3), C11–O2 1.374(3), O2–C12 1.383(3),
O1–C11–O2 124.0(2), C1–C11–O2–C12 170.9(2).
Fig. 3. Molecular structure of Ru2(CO)4(OOCC5H4FeC5H5)2(NC5H4-
OOCC5H4FeC5H5)2 (4), the chloroform molecules and the hydrogen
atoms are omitted for clarity. Selected bond distances (A˚), angles and
torsion angles: Ru1–Ru2 2.6850(7), Ru1–O3 2.123(4), Ru1–O5 2.120(4),
Ru2–O4 2.104(4), Ru2–O6 2.112(4), Ru1–N1 2.253(4), Ru2–N2 2.210(5),
O3–C19–O5 125.2(6), O5–C30–O6 125.7(5), N1–Ru1–Ru2–N2 8.9(6).
Fig. 4. Encapsulation of a CHCl3 molecule between the two ferrocenyl
substituents of the bridging ligands in 4.
Fig. 5. Molecular structure of Ru2(CO)4(HNOCC5H4FeC5H5)2(PPh3)2
(5), the hydrogen atoms are omitted for clarity. Selected bond distances
(A˚) and angles (): Ru1–Ru1i 2.7697(6), Ru1–N1i 2.128(3), Ru1–O1
2.127(2), Ru1–P1 2.4133(9), O1–C1–N1 122.9(3).
5solution was stirred at room temperature for 3 h, the solu-
tion was evaporated and the product isolated from the res-
idue by crystallization from a chloroform/hexane mixture.
In order to improve the purity, the raw product was sub-
jected to a thin-layer chromatography on silica gel using
a dichloromethane/hexane mixture (1:1) as eluent and
obtained as yellow powder. Yield: 81% (327 mg,
0.25 mmol). 1H NMR (400 MHz, CDCl3): d = 7.82–
7.60 ppm (m, 12H), 7.59–7.43 (m, 18H), 3.97 (t, 4H), 3.88
(s, 10H), 3.83 (d, 2H), 3.66 (d, 2H); 31P{1H} NMR (162
MHz, CDCl3): d = 21.09 ppm; IR (CaF2, CH2Cl2): m(CO)
2011 vs, 1967 m, 1939 vs, m(OCNH) 1551 s cm
1; ESI–MS:
1296 [M + H+]; Anal. Calc. for C62H50Fe2N2O6-
P2Ru2(1294.85), C, 57.51; H, 3.89; N, 2.16. Found: C,
55.73; H, 3.93; N, 1.99% (C62H50Fe2N2O6P2Ru2 Æ 2H2O).3.5. X-ray crystallography
Single-crystals of 1–5, obtained by slow diﬀusion of hex-
ane into a solution of the complex (THF: 1, 2; CHCl3: 3–5),
were mounted on a Stoe Image Plate Diﬀraction system
equipped with a / circle goniometer, using Mo Ka graphite
monochromated radiation (k = 0.71073 A˚) with / range 0–
200, increment varying from 0.7 to 2.0, Dmax 
Dmin = 12.45–0.81 A˚. The structures were solved by direct
methods using the program SHELXS-97 [15]. The reﬁnement
and all further calculations were carried out using SHELXL-
97 [16]. In all compounds the hydrogen atoms have been
included in calculated positions and treated as riding atoms
using the SHELXL default parameters. All non-H atoms were
reﬁned anisotropically, using weighted full-matrix least-
square on F2. In 4, one –OCO– fragment of a carboxylato
was found to be disorder over two positions and the partial
6occupancy factor was ﬁxed at 50:50. In 4, the residual den-
sities greater than 1 e A˚3 are located closed to the chloride
atoms of the solvent molecules. Crystallographic details are
summarized in Table 1. Figs. 1–3 and 5 were drawn with
ORTEP [17] and Fig. 4 with MERCURY [18].
4. Supplementary material
CCDC-280633 1 Æ THF, 280634 2, 280635 3, 280636
4 Æ 2CHCl3 and 280637 5 contain the supplementary crystal-
lographic data for this paper. These data can be obtained
free of charge via www.ccdc.cam.ac.uk/data_request/cif,
by e-mail:data_request@ccdc.cam.ac.uk, or by contacting
The Cambridge Crystallographic Data Centre, 12, Union
Road, Cambridge CB2 1EZ, UK (fax: +44 1223 336033).
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